Back
Fortive Corp. 10K Form
Sell
39
FTV
Fortive Corp.
Last Price:
$53.41
Seasonality Move:
1.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-25 | 10Q | FTV/Fortive Corp. Quarterly |
| 2023-07-26 | 10Q | FTV/Fortive Corp. Quarterly |
| 2023-04-26 | 10Q | FTV/Fortive Corp. Quarterly |
| 2022-10-26 | 10Q | FTV/Fortive Corp. Quarterly |
| 2022-07-28 | 10Q | FTV/Fortive Corp. Quarterly |
| 2022-04-28 | 10Q | FTV/Fortive Corp. Quarterly |
Receive FTV News And Ratings
See the #1 stock for the next 7 days that we like better than FTV
FTV Financial Statistics
Sales & Book Value
| Annual Sales: | $6.2B |
|---|---|
| Cash Flow: | $153.1M |
| Price / Cash Flow: | 16.48 |
| Annual Sales: | $20.48 |
| Price / Book: | 2.61 |
Profitability
| EPS (TTM): | 1.75140 |
|---|---|
| Net Income (TTM): | $664.3M |
| Gross Margin: | $3.7B |
| Return on Equity: | 6.93% |
| Return on Assets: | 4.06% |
Fortive Corp. Earnings Forecast
Key Fortive Corp. Financial Ratios
-
The Gross Profit Margin over the past 13 years for FTV is 59.87%.
-
The Selling, General & Administrative Expenses for FTV have been equal to 34.88% of Gross Profit Margin.
-
The Research & Development expenses have been 6.64% of Revenue.
-
The Interest Expense is 18.35% of Operating Income.
-
The Net Earning history of FTV is 13.37% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 8 years.
Fortive Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Machinery |
| Sector: | Industrials |
| Current Symbol: | FTV |
| CUSIP: | 34959J |
| Website: | fortive.com |
Debt
| Debt-to-Equity Ratio: | 0.51 |
|---|---|
| Current Ratio: | 0.67 |
| Quick Ratio: | 0.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.61 |
|---|---|
| Forward P/E Ratio: | 18.75 |
FTV Technical Analysis vs Fundamental Analysis
Sell
39
Fortive Corp. (FTV)
is a Sell
Is Fortive Corp. a Buy or a Sell?
-
Fortive Corp. stock is rated a SellThe current Fortive Corp. [FTV] share price is $53.38. The Score for FTV is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.